The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Neuroleptic medications inhibit complex I of the electron transport chain
Abstract
Neuroleptic medications are prescribed to millions of patients, but their use is limited by potentially irreversible extrapyramidal side effects. Haloperidol shows striking structural similarities to the neurotoxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetra‐hydropyridine, which produces parkinsonism apparently through inhibition of NADH:ubiquinone oxidoreductase (complex I) of the mitochondrial electron transport chain. We now report that haloperidol chlorpromazine, and thiothixine inhibit complex I in vitro in rat brain mitochondria. Clozapine, an atypical antipsychotic reported to have little or no extrapyramidal toxicity, also inhibits complex I, but at a significantly higher concentration. Neuroleptic treated patients have significant depression of platelet complex I activity similar to that seen in idiopathic Parkinson's disease. Complex I inhibition may be associated with the extrapyramidal side effects of these drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates
Bodis-Wollner, I., Chung, E., Ghilardi, M. F., Glover, A., Onofrj, M., Pasik, P., & Samson, Y. (1991) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02251137 · Cited by 51
Cited by
Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview
Mariani, E., Polidori, M. C., Cherubini, A., & Mecocci, P. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.04.023 · Cited by 680
Statin Adverse Effects: A Review of the Literature and Evidence for a Mitochondrial Mechanism
Golomb, B. A., & Evans, M. A. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/0129784-200808060-00004 · Cited by 677
Inhibitors of NADH–ubiquinone reductase: an overview
Degli Esposti, M. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00029-2 · Cited by 528
Molecular Evidence for Mitochondrial Dysfunction in Bipolar Disorder
Konradi, C., Eaton, M., MacDonald, M. L., Walsh, J., Benes, F. M., & Heckers, S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.300 · Cited by 501
Iwamoto, K., Bundo, M., & Kato, T. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi022 · Cited by 495
Impaired mitochondrial function in psychiatric disorders
Manji, H., Kato, T., Di Prospero, N. A., Ness, S., Beal, M. F., Krams, M., & Chen, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3229 · Cited by 483
Mitochondrial Dysfunction and Psychiatric Disorders
Rezin, G. T., Amboni, G., Zugno, A. I., Quevedo, J., & Streck, E. L. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9865-8 · Cited by 442
Haas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., & Shults, C. W. (1995) · Annals of Neurology · doi:10.1002/ana.410370604 · Cited by 435
Mitochondrial Generation of Reactive Oxygen Species After Brain Ischemia in the Rat
Piantadosi, C. A., & Zhang, J. (1996) · Stroke · doi:10.1161/01.str.27.2.327 · Cited by 394
Mitochondrial dysfunction in bipolar disorder
Kato, T., & Kato, N. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020305.x · Cited by 380
Benzi, G., & Moretti, A. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00244-e · Cited by 283
Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
Banerjee, R., Starkov, A. A., Beal, M. F., & Thomas, B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.007 · Cited by 253
(2009) · PubMed · Cited by 95
The Psychiatric Presentation of Mitochondrial Disorders in Adults
Anglin, R. E., Tarnopolsky, M. A., Mazurek, M. F., & Rosebush, P. I. (2012) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.11110345 · Cited by 77
The neuropsychiatry of adult-onset adrenoleukodystrophy
Rosebush, P. I., Garside, S., Levinson, A. J., & Mazurek, M. F. (1999) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.11.3.315 · Cited by 72
De Simone, G., Mazza, B., Vellucci, L., Barone, A., Ciccarelli, M., & de Bartolomeis, A. (2023) · Antioxidants · doi:10.3390/antiox12040975 · Cited by 49
In vitro effects of antipsychotics on mitochondrial respiration
Cikánková, T., Fišar, Z., Bakhouche, Y., Ľupták, M., & Hroudová, J. (2019) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-019-01665-8 · Cited by 44
Psychotropic medications and mitochondrial toxicity
Anglin, R., Rosebush, P., & Mazurek, M. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3229-c1 · Cited by 17
Psychiatric care for a person with MELAS syndrome: A case report
Leong, D. Y., Chee, R. Y., & Lui, Y. S. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4146 · Cited by 2
Metadata
- Authors
- Burkhardt, C., Kelly, J. P., Lim, Y., Filley, C. M., & Parker, W. D.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1993-05
- Volume
- 33
- Issue
- 5
- Pages
- 512-517
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1986651279
- Cited by
- 219
- References
- 2
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.